WPC'H cs7gK=ծ0;oz04|\qi 8MꥳG4H렭~ri&jhiM>f1Uh6 /wg.U`Pu% Kg|n?P8gI=?R%9ҲPCg}r[Ur_J!O^JªT3- );X8eL=:℉S&~,BnڧYԅRk H4=Kӑz򼷅uQ~~b](dUDgSQ$;j09TrAbS@U̺OӦ" ͵ ';~9_mbɖ׮)jkdγ0a?xӖsAoϵ{ּ Dτ[ R:cEJ61iMML"?2r>& ;q};?xs;kto<,j][2;Q`;:U)N, %z 0#w(@ 4h m>w^ 4Z& 0 ( B-d 0;9 0Dt  #l&x ) ) ) 0,*-*------------------(..../(00022222f3f3f3f3f3f3f3f3f3f3f3f3f3f3f3f3f3f3f3f3f3f3f3f3f3f3f3f3f3f3f3N>4>4>4>4>4 1@4@4 04444 077 0:: 0u>> 0w>> 0?? 0?? 1ud@d@d@d@ B@@@@$@@@@@@@@@@@@ 72BB/LBLB 1{B{B{B{B{B{B{B{B{B{B{B{B{B{B{B{B{B{B{B{B{BU:CCCCMVCVCVCVCDZCZCZCZCZCZCZCZCZCZCZCZCZCZCZCZCZCZCZCZCZCZCZCZCZCZCZCZCZCZCZCZCZCZCZCZCZCZCZCZCZCZCZCZCZCZCZCZCZCZCZCZCZCZCZCZCZCZCZCZCZCZCZCZCZCZCZCZCZCZCZCZCZCZCZCZCZCZCZCZCZCZCZCZCZCZCZCZCZCZCZCZCZCZCZCZCZCZCZCZCZCZCZCZCZCZCZCZCZCZCZCZCZCZCZCZCZCZCZCZCZCZCZCZCZCZCZCZCZCZCZCZCZCZCZCZCZCZCZCZCZCZCZC 0DDE 0 FF 0eG&d9 Z6Times New Roman RegularX($,..,VTRW6&A4W6&A4 6&A4 6&A4T ? VV0?vvbX0#ggdd  8Vdd8ISUS,.     ^^` Adobe PDF0 W:\WP2000\SKJRI~IZ.WPTUW:\WP2000\SkjritunY2k-nytt.wptOOvN:i+003|x8DocumentManagement::ModifiedBooleanTRUE($)Hairline d Z $,..,XXXX? XX0?vvbX0#ggdd  ISUS,.    1  0   J48   5  https://www.who.int/medicines/publications/WHO-PPL-Short_Summary_25Feb-ET_NM_WHO.pdf6Th  7 o#J5#_(%2$ !,..,XfXXXTRW6&A4X3' Letter 6&A43'LetterT ? XXf0?vvbX0#ggdd  8dd8ISUS,.     ^^`     0  0  (#$  0    $,..,XXXX? XX0?vvbX0#ggdd  ISUS,.    2  0   __4;   5  Jhttps://www.who.int/news-room/detail/20-09-2017-the-world-is-running-out-of-antibiotics-who-__report__-confirms#J#6Ui  7 ___  $,..,XXXX? XX0?vvbX0#ggdd  ISUS,.    3  0   __4   5  Jhttps://ecdc.europa.eu/en/news-events/gonorrhoea-drug-resistance-compromises-recommended-_treatment_-europe#J#6Ui  7 _  $,..,XXXX? XX0?vvbX0#ggdd  ISUS,.    4  0   _J46   5  https://_amr_-review.org/_sites_/default/files/160525_Final%20paper_with%20cover.pdf6dx  7 #JE# n $,..,XXXX? XX0?vvbX0#ggdd  ISUS,.    5  0   _J42   5  https://_www.ema.europa.eu_/en/_documents_/report/_sales_-veterinary-_antimicrobial_-agents-30-european-_countries_-2016  -trends-2010-2016-eighth-_esvac_en.pdf6dx  7 } _#JE#T : l*umgrum einstakar greinar  Um1  .ۀgr.  umLevel 1Level 2Level 3Level 4Level 5https://ecdc.europa.eu/en/news-events/gonorrhoea-drug-resistance-compromises-recommended-treatment-europe  a',..,XXXX? XX0?vvbX0#ggdd  ISUS,.   _Ԁ3https://www.ema.europa.eu/en/documents/report/sales-veterinary-antimicrobial-agents-30-european-countries-2016-trends-2010-2016https://www.ema.europa.eu/en/documents/report/sales-veterinary-antimicrobial-agents-30-european-countries-2016-trends-2010-2016-eighth-esvac_en.pdfhttps://amr-review.org/sites/default/files/160525_Final%20paper_with%20cover.pdfhttps://www.who.int/medicines/publications/WHO-PPL-Short_Summary_25Feb-ET_NM_WHO.pdfhttps://www.who.int/news-room/detail/20-09-2017-the-world-is-running-out-of-antibiotics-who-report-confirmsikmo %Eu{}1. a. 1.StafliWir undir t?luliW1.a.1.(3$ !,..,XfXXXTRW6&A4X3' Letter 6&A43'LetterT ? XXf0?vvbX0#ggdd  8dd8ISUS,.     ^^`   (3$ !,..,XfXXXTRW6&A4X3' Letter 6&A43'LetterT ? XXf0?vvbX0#ggdd  8dd8ISUS,.     ^^`   (3G$ !,..,XfXXXTRW6&A4X3' Letter 6&A43'LetterT ? XXf0?vvbX0#ggdd  8dd8ISUS,.     ^^`    d (M0J$2  0  .3  0 ` (O;$0  2#  a  .3  0` (#(#(u$0  0` (#(#` `  2  a  .3  0` (#` (#(`$0  0` (#(#0 ` (#` (#0 (# (#"h2  0  .3  0(#(#3#37=CIQYag1.a.i.(1)(a)(i)1)a) d  gG+,..,XXXX? XX0?vvbX0#ggdd  ISUS,.   d  ݀qi) %y_ gEu{}a. 1. a.T?luliWur undir stafliWa.1.a.1)a)4cp Z "Times Regular : e),..,XXXX? XX0?vvbX0#ggdd  ISUS,.   _>? Ҁ8_ z,kaflikafli  6III  .6ۀKAFLI     kaflanumerLevel 1Level 2Level 3Level 4Level 5F 7 #,greingreinarnCmer  83  .8ۀgr.  greinLevel 1Level 2Level 3Level 4Level 5X[ |0greinmfgrein meW fyrirs?gn  84  .8ۀgr.    !,..,XXXXTRW6&A4X3' Letter 6&A43'LetterT ? XX0?vvbX0#ggdd  8dd8ISUS,.     ^^`   _ >?  _ikmo(%03q. 9150.lggjafarYing2019!2020. ( Xingskjal247"229.ml.      XFrumvarptillaga# Xf#   W  umbreytingulgumummatvli,nr.93/1995,   meWsWaribreytingum(sUklalyfjanotkun).   X Flm.:GunnarBragiSveinsson,AnnaKolbrnrnad;ttir,BergY;r:lason,    ElvarEyvindsson,KarlGautiHjaltason,:lafur0sleifsson,    SigurWurPllJ;nsson,XorgrmurSigmundsson,   XorsteinnSmundsson. wO    1.gr.      eftir15.gr.lagannakemurnUgrein,15.gr.a,svohlj;Wandi:     FyrirtkisemhafameWhndumsmslumatvlaskulutryggjameWmerkingumslu {  rUmumaWneytendurhafigreiWanaWgangaWupplUsingumumupprunalandmatvlannaog nF meWalnotkunsUklalyfjaviWframleiWslumatvlaviWkomandilandi.Matvlastofnunskal 9 rlegagefatleiWbeiningarummiWlunupplUsingaumsUklalyfjanotkunviWframleiWslumat  vla.    2.gr. e= x   LgYessiWlastYegargildi. 0 #dgg  GreinargerW.#ggd      FrumvarpiWvarWurlagtfram149.lggjafarYingi(753.ml).MarkmiWfrumvarpsins i eraWbtamiWlunupplUsingaumsUklalyfjanotkunviWframleiWslumatvlatilneytenda.MeW \4 YessuertryggtaWneytendursuupplUstirummeWalnotkunsUklalyfjaviWframleiWslumat ' vlaupprunalandiYeirramatvlasemboWinerutilslumatvruverslunumoggetibyggt  kvarWanirsnarumvalmatvruYeimupplUsingum.    0byrjunrs2017birtiAlYj;WaheilbrigWismlastofnunin(WHO)listayfirsUklalyfja `  ;nmarbakterurYarsemstofnuninflokkaWit;lfttirbakteraeftirhttuflokkum. #  1      ׀HaustiW S+! 2019varaWistofnuninviWaWjarWarbarvruaWverWauppiskroppameWnothfsUklalyfog " hvattitilYr;unarnUrralyfja.AWalframkvmdastj;ristofnunarinnar,dr.TedrosAdhanom # Ghebreyesus,lUstiYvyfir20.september2017aWneyWarstandvriaWskapastmeWhndl  $ unsjklingavegnasUklalyfja;nmis. #  2      ׀XkemurframnUrriskUrsluEvr;pusambandsinsfr !W% Yvfebrar2019S #  3      ׀aWaukiW;nmigegnsUklalyfjumstofnihttuhefWbundinnimeWferW J""& viWlekanda,semernstalgengastikynsjkd;murinnanEESsvWisins.0skUrslusemunnin #' varBretlandiumaWgerWirgegnsUklalyfja;nmumbakterumkemurframaWrlegaltium #( 700.000mannslfiWheimsvsuafvldumslkrabaktera. #  4      ׀ $ ) 9 y     12.aprl2017skilaWistarfsh;pur,skipaWurafheilbrigWisrWherra,greinargerWumaWgerWir ( tilaWdragartbreiWslusUklalyfja;nmrabaktera0slandi.0greinargerWinnikemurm.a.  framaWsUklalyfjanotkundUrumhrlandihefurveriWeinslgstaheimsvsu.Xhafi  algengisUklalyfja;nmishrlandiveriWumtalsvertlgraenngrannalndum.0greinar a gerWstarfsh;psinsogbreskuskUrslunnierfjallaWummikilvgiYessaWaukameWvitund T, almenningsumhttunasemfylgirofnotkunsUklalyfja.XergreinargerWstarfsh;psinslagt  tilaWinnleiddverWistefnaumskynsamleganotkunsUklalyfjadUrum,m.a.verWigefnart  leiWbeiningarumskynsamleganotkunYeirra.X;ttmikiWhafiveriWfjallaWumnotkunsUkla   lyfjaoghttunasemfylgirsUklalyfja;nmumbakterumhefurheildstWastefnuvantaW  X 0slandi. K #    LyfjastofnunEvr;pugefurrlegatskUrsluumslusUklalyfjasemtluWerudUrum30    rkjumEvr;pu. #  5      ׀0YeirriskUrslumfinnaupplUsingarumnotkunsUklalyfjahelstuinnflutn    ingsrkjum0slands.NauWsynlegteraWaukavitundalmenningsumefniskUrslunnarenda   hefurskortmikiWmiWlunupplUsingatilalmenningsumnotkunsUklalyfjaviWframleiWslu wO  matvla.HafialmenningurgreiWanaWgangaWYessumupplUsingumslurUmumverslana B  getaneytendurtekiWkvrWunumfrhvaWarkjumYeirkaupamatvligrundvelliopin    berraupplUsingaumnotkunsUklalyfjamatvlaframleiWslu.